Author
Pritchard, AndrewBurns, Paul
Correia, Joao
Jamieson, Patrick
Moxon, Peter
Purvis, Joanna
Thomas, Maximillian
Tighe, Hannah
Sylvester, Karl Peter
Publication date
2021-11Subject
Cardiology
Metadata
Show full item recordAbstract
Cardiopulmonary exercise testing (CPET) has become an invaluable tool in healthcare, improving the diagnosis of disease and the quality, efficacy, assessment and safety of treatment across a range of pathologies. CPET's superior ability to measure the global exercise response of the respiratory, cardiovascular and skeletal muscle systems simultaneously in a time and cost-efficient manner has led to the application of CPET in a range of settings from diagnosis of disease to preoperative assessment. The Association for Respiratory Technology and Physiology Statement on Cardiopulmonary Exercise Testing 2021 provides the practitioner and scientist with an outstanding resource to support and enhance practice, from equipment to testing to leadership, helping them deliver a quality assured service for the benefit of all patient groups.Citation
Pritchard A, Burns P, Correia J, Jamieson P, Moxon P, Purvis J, Thomas M, Tighe H, Sylvester KP. ARTP statement on cardiopulmonary exercise testing 2021. BMJ Open Respir Res. 2021 Nov;8(1):e001121. doi: 10.1136/bmjresp-2021-001121Type
ArticleAdditional Links
http://bmjopenrespres.bmj.com/PMID
34782330Journal
BMJ Open Respiratory ResearchPublisher
BMJ Publishing Groupae974a485f413a2113503eed53cd6c53
10.1136/bmjresp-2021-001121